Mbpharmaco Consulting Ltd
14702698
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/03/2026
micro entity
Next accounts due
31/12/2027
Confirmation statement
Last: 06/03/2026
Due 20/03/2027
Industry
Officers
Persons with Significant Control
Almisbah Beerahee
British · England · Age 68
4th Floor 205, Regent Street, London, W1B 4HB
Notified 03/03/2023
Christine Rose Beerahee
British · England · Age 68
79, Wilbury Hills Road, Letchworth Garden City, SG6 4LD
Notified 03/03/2023
CompanyRankvs 930+ SIC 72110 peers64
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Turnover
£219k
Annual revenue
Net Worth
£78k
Balance sheet strength
Cash
£85k
Cash in the bank
Profit Before Tax
£59k
Bottom line earnings
Net Current Assets
£78k
Working capital
Current Assets
£90k
Current Liabilities
£12k
Debtors
£5k
Cost of Sales
£0
Gross Profit
£219k
Admin Expenses
£160k
Operating Profit
£59k
Profit After Tax
£47k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 7.37 | -£7k |
| 2024 | 11.33 | — |
Derived from filed accounts. Not audited figures.